This 3-armed randomized controlled trial aims to evaluate the effectiveness of The Microclinic Behavioral Health Program in improving obesity and diabetes risk factors through a behavioral intervention program structured to enhance and promote social-network interactions and social support. The full version of the Microclinic Behavioral Health Program (Full MCP) with program-activated social-network interactions-with shared access to diabetes education, technology, and group support to promote weight and metabolic control through diet, exercise, medication adherence, and blood pressure management. Participants play a role in the collective effort to combat diabetes and solidifying self-management behavioral skills through peer-monitoring and encouragement of lifestyle behaviors. The study may yield valuable information on the impact of social support and social network interactions for enhancing body weight and blood sugar control. We compare the full MCP intervention, to a basic MCP intervention with more limited classroom interaction, and to an parallel monitoring control arm. And we aim to understand how metabolic changes over time relate to the cross-propagation of health behaviors between persons in social networks. This Microclinic Behavioral Health Program was established in collaboration with the Royal Health Awareness Society (RHAS) and the Jordanian Ministry of Health (MoH).
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Longitudinal change in body weight across all trial arms, over entire study
Timeframe: Overall change across baseline, to 6 months, to 2 years
Longitudinal change in fasting blood glucose across all trial arms, over entire study
Timeframe: Overall change across baseline, to 6 months, to 2 years
Longitudinal change in glycosylated hemoglobin (HbA1c) across all trial arms, over entire study
Timeframe: Overall change across baseline, to 6 months, to 2 years
Longitudinal change in blood pressure across all trial arms, over entire study
Timeframe: Overall change across baseline, to 6 months, to 2 years
Temporally investigate the causal induction of cascading changes in body weight between follow-ups on subsequent weight changes in other participants.
Timeframe: Change from each session (weekly, biweekly, triweekly), on each subsequent session, during 6 month intervention period.